The National Institutes of Health (NIH) funded a landmark study that supports a crucial component of the 2017 Hypertension
Clinical Practice Guidelines put forth by the American Heart Association (AHA) and the American College of Cardiology (ACC). The AHA and ACC guidelines state that high blood pressure should be treated earlier by changes in lifestyle and medications for some. The new guideline recommends treatment at 130/80 instead of 140/90.
Recommendations are the result of the Systolic Blood Pressure Intervention Trial (SPRINT) that was designed to determine how to best treat adults with high blood pressure, over the age of 50, and at risk for heart disease. SPRINT was sponsored in part by the National Heart, Lung, and Blood Institute (NHLBI), and the National Institute of Diabetes and Digestive and Kidney Disease (NIDDK), the National Institute of Neurological Disorders and Stroke (NINDS) and The National Institute of Aging (NIA), divisions of the National Institutes of Health.
Thoughts on "NIH Blood Pressure Study Data Supports AHA/ACC Hypertension Guidelines"